Pages that link to "Q37798546"

The following pages link to Nucleoside reverse transcriptase inhibitor toxicity and mitochondrial DNA (Q37798546):

Displaying 37 items.

• DNA polymerase γ and disease: what we have learned from yeast (Q26825324) (← links)
• Caenorhabditis elegans as a Model System for Studying Drug Induced Mitochondrial Toxicity (Q28547224) (← links)
• HIV-1 infection and first line ART induced differential responses in mitochondria from blood lymphocytes and monocytes: the ANRS EP45 "Aging" study (Q28729025) (← links)
• Azidothymidine-triphosphate impairs mitochondrial dynamics by disrupting the quality control system (Q33874792) (← links)
• Aging and HIV/AIDS: pathogenetic role of therapeutic side effects (Q34089694) (← links)
• Truncated reverse isoxazolidinyl nucleosides: a new class of allosteric HIV-1 reverse transcriptase inhibitors (Q34253409) (← links)
• Association of thymidylate synthase polymorphisms with acute pancreatitis and/or peripheral neuropathy in HIV-infected patients on stavudine-based therapy (Q34612023) (← links)
• Identification and characterization of a novel HIV-1 nucleotide-competing reverse transcriptase inhibitor series (Q34643481) (← links)
• Polymorphisms in DNA polymerase γ affect the mtDNA stability and the NRTI-induced mitochondrial toxicity in Saccharomyces cerevisiae (Q35024623) (← links)
• The "fast" and the "slow" modes of mitochondrial DNA degradation (Q35097108) (← links)
• Mechanism of interaction of human mitochondrial DNA polymerase γ with the novel nucleoside reverse transcriptase inhibitor 4'-ethynyl-2-fluoro-2'-deoxyadenosine indicates a low potential for host toxicity. (Q35806294) (← links)
• Probing the structural and molecular basis of nucleotide selectivity by human mitochondrial DNA polymerase γ (Q35865595) (← links)
• Metal-induced DNA translocation leads to DNA polymerase conformational activation (Q35888841) (← links)
• Structural basis for processivity and antiviral drug toxicity in human mitochondrial DNA replicase (Q35991650) (← links)
• Balancing antiviral potency and host toxicity: identifying a nucleotide inhibitor with an optimal kinetic phenotype for HIV-1 reverse transcriptase (Q36057386) (← links)
• Validation of A Point-of-Care Lactate Device For Screening At-Risk Adults Receiving Combination Antiretroviral Therapy In Botswana (Q36329990) (← links)
• Acute pancreatitis in HIV/AIDS patients: an issue of concern (Q36817085) (← links)
• The role of transporters in the toxicity of nucleoside and nucleotide analogs (Q36921993) (← links)
• Ethambutol induced toxic optic neuropathy in HIV positive patients (Q37126897) (← links)
• Development of a vaginal delivery film containing EFdA, a novel anti-HIV nucleoside reverse transcriptase inhibitor (Q37687006) (← links)
• Tempol protects cardiomyocytes from nucleoside reverse transcriptase inhibitor-induced mitochondrial toxicity (Q37722849) (← links)
• HIV-associated sensory neuropathy: risk factors and genetics (Q37988382) (← links)
• The purine analogues abacavir and didanosine increase acetaminophen-induced hepatotoxicity by enhancing mitochondrial dysfunction. (Q38805500) (← links)
• Cardiomyocytes are Protected from Antiretroviral Nucleoside Analog-Induced Mitochondrial Toxicity by Overexpression of PGC-1α. (Q38942113) (← links)
• Molecular analysis of mitochondrial compromise in rodent cardiomyocytes exposed long term to nucleoside reverse transcriptase inhibitors (NRTIs). (Q39428374) (← links)
• NRTI backbone in HIV treatment: will it remain relevant? (Q39533858) (← links)
• From the Cover: Investigative Nonclinical Cardiovascular Safety and Toxicology Studies with BMS-986094, an NS5b RNA-Dependent RNA Polymerase Inhibitor (Q40444671) (← links)
• Fibroblast growth factor 23: associations with antiretroviral therapy in patients co-infected with HIV and hepatitis C. (Q41033591) (← links)
• Transgenic mouse model with deficient mitochondrial polymerase exhibits reduced state IV respiration and enhanced cardiac fibrosis (Q41940970) (← links)
• Bifunctional inhibition of human immunodeficiency virus type 1 reverse transcriptase: mechanism and proof-of-concept as a novel therapeutic design strategy (Q42537068) (← links)
• Off-Target Effects of Drugs that Disrupt Human Mitochondrial DNA Maintenance (Q47125109) (← links)
• Myoblast mitochondrial respiration is decreased in chronic binge alcohol administered simian immunodeficiency virus-infected antiretroviral-treated rhesus macaques. (Q52674611) (← links)
• Cardiac and mitochondrial function in HIV-uninfected fetuses exposed to antiretroviral treatment (Q64040134) (← links)
• Pyrimidine 2,4-Diones in the Design of New HIV RT Inhibitors. (Q64969081) (← links)
• Some Aspects of CD8+ T-Cell Exhaustion Are Associated With Altered T-Cell Mitochondrial Features and ROS Content in HIV Infection (Q90074402) (← links)
• Analysis of Human Mitochondrial DNA Content by Southern Blotting and Nonradioactive Probe Hybridization (Q93078192) (← links)
• Mitochondrial DNA Parameters in Blood of Infants Receiving Lopinavir/Ritonavir or Lamivudine Prophylaxis to Prevent Breastfeeding Transmission of HIV-1 (Q99555977) (← links)